News: Biocon drug Itolizumab has been approved by the Drugs Controller General of India(DCGI) for treating moderate to severe Covid-19 patients. Facts: Itolizumab: It is a monoclonal antibody drug manufactured by Biocon for the treatment of severe chronic plaque psoriasis. Monoclonal antibodies are lab-made proteins that act like human antibodies in the immune system and… Continue reading Biocon Gets Regulatory Nod To Use Drug Itolizumab On COVID-19 Patients
Tag: Itolizumab
Search Articles
Latest Articles
- [Answered] UPSC Mains Answer writing 28 Mar, 2024 I Mains Marathon
- UPSC Prelims Marathon 29th March – Public Finance in India – 2024
- 10 PM UPSC Current Affairs Quiz 28 March, 2024
- 9 PM UPSC Current Affairs Articles 28 March, 2024
- India’s urban water crisis-From Bengaluru to Chennai and beyond
- Limitation of Welfare Policies Politics in India
- Challenges of implementing a wealth tax: Piketty’s wealth tax: An idea that just can’t work
- Avoid pre-trial injunctions against the media in defamation cases: Timely restatement
- Impact of politics on humanitarian aid: The politics of humanitarian aid
- Investment Facilitation for Development (IFD): WTO’s investment facilitation negotiations are not illegal